BIOMAT Database Logo BIOMAT Database Logo

[Seroprevalence of HBV, HCV and HDV hepatitis markers in 500 patients infected with the human immunodeficiency virus]. 1997

F Denis, and C C Adjide, and S Rogez, and C Delpeyroux, and J P Rogez, and P Weinbreck
Département de Bactériologie-Virologie-Hygiène (Equipe CNRS: EP 0118), Limoges, France.

The serological status for both hepatitis B, C and D viruses was analyzed for 500 HIV seropositive patients and for 1037 of a control group. The prevalence was 31.4% for anti HCV, 13.8% for HBs Ag and 69.0% for one or more HBV markers in HIV positive patients and respectively 2.5%, 2.7% and 13.1% in control group. The markers for hepatitis D were founded among 21% of the HBs Ag carriers (patients and control group), correlated with drug i.v. use. The prevalence of anti-HCV was 71.6% in subjects who had blood-borne HIV infection and 1.5% in those with sexually acquired infection. The prevalence in control group was 10.2% and 1.7% respectively according to the same risk factors. The prevalence of HBs Ag was higher among HIV positive patients with sexual risk (17.5%) than with blood exposition (9.9%) and a variation in the same direction is observed in control group (3% v.s. 1%). The relation between markers for hepatitis B and hepatitis C was negative.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003698 Hepatitis Delta Virus A defective virus, containing particles of RNA nucleoprotein in virion-like form, present in patients with acute hepatitis B and chronic hepatitis. It requires the presence of a hepadnavirus for full replication. This is the lone species in the genus Deltavirus. Delta Agent,Delta Virus,Deltavirus,Hepatitis D Virus,Delta Agents,Delta Virus, Hepatitis,Delta Viruses,Delta Viruses, Hepatitis,Deltaviruses,Hepatitis D Viruses,Hepatitis Delta Viruses
D005260 Female Females
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor

Related Publications

F Denis, and C C Adjide, and S Rogez, and C Delpeyroux, and J P Rogez, and P Weinbreck
Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
January 2018, PloS one,
F Denis, and C C Adjide, and S Rogez, and C Delpeyroux, and J P Rogez, and P Weinbreck
Prevalence of HBV, HDV and HCV hepatitis markers in HIV-positive patients.
April 1995, European journal of epidemiology,
F Denis, and C C Adjide, and S Rogez, and C Delpeyroux, and J P Rogez, and P Weinbreck
Seroprevalence of hepatitis viruses in patients infected with the human immunodeficiency virus.
January 2009, Indian journal of pathology & microbiology,
F Denis, and C C Adjide, and S Rogez, and C Delpeyroux, and J P Rogez, and P Weinbreck
[Seroprevalence of hepatitis C in human immunodeficiency virus infected patients].
February 1991, Pathologie-biologie,
F Denis, and C C Adjide, and S Rogez, and C Delpeyroux, and J P Rogez, and P Weinbreck
PCR-Based Molecular Diagnosis of Hepatitis Virus (HBV and HDV) in HCV Infected Patients and Their Biochemical Study.
January 2016, Journal of pathogens,
F Denis, and C C Adjide, and S Rogez, and C Delpeyroux, and J P Rogez, and P Weinbreck
[Detection of hepatitis delta virus (HDV) markers in HBV carriers].
September 1992, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
F Denis, and C C Adjide, and S Rogez, and C Delpeyroux, and J P Rogez, and P Weinbreck
Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection.
August 2018, Journal of viral hepatitis,
F Denis, and C C Adjide, and S Rogez, and C Delpeyroux, and J P Rogez, and P Weinbreck
[Seroprevalence of Hepatitis B virus (HBV), Hepatitis C virus (HCV) and Human Immunodeficiency Virus (HIV) in a sample of patients diagnosed with Alcohol User Disorder in Albacete (Spain).]
May 2022, Revista espanola de salud publica,
F Denis, and C C Adjide, and S Rogez, and C Delpeyroux, and J P Rogez, and P Weinbreck
Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
January 2008, Antiviral therapy,
F Denis, and C C Adjide, and S Rogez, and C Delpeyroux, and J P Rogez, and P Weinbreck
[Hepatitis virus (HBV, HCV, HDV) markers in chronic liver diseases. Comparative studies in two East-Central European countries].
July 1992, Orvosi hetilap,
Copied contents to your clipboard!